Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Terminated 1Completed 1Active not recruiting 1

Sponsor Class

NETWORK 13OTHER 3NIH 2

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 16Gastrointestinal 13Head & Neck 8Breast 8CNS 6Gynecologic 3Genitourinary 3Sarcoma 2Other solid neoplasm 2Dermatologic 1

Conditions

Prostatic Neoplasms 2Urinary Bladder Neoplasms 1

Interventions

Docetaxel 229Radiotherapy 206Magnetic Resonance Spectroscopy 204Radiosurgery 176Gemcitabine 155pembrolizumab 151Nivolumab 147enzalutamide 140Prednisone 129Cisplatin 123Leuprolide 119Androgen Antagonists 117Abiraterone Acetate 114Sunitinib 106Specimen Handling 94Surveys and Questionnaires 91Goserelin 91bicalutamide 90Carboplatin 88Ipilimumab 82gallium 68 PSMA-11 80Blood Specimen Collection 78Everolimus 73apalutamide 72Radiation 71Standard of Care 68Biopsy 68acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 66Paclitaxel 64Cyclophosphamide 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Radiotherapy, Conformal × Genitourinary × Clear all
NCT00667069 2025-06-05

Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer

UNICANCER

Phase 3 Completed
424 enrolled
Genitourinary

Prostatic Neoplasms

NCT00967863 2024-12-18

Radiation Therapy in Treating Patients Receiving Hormone Therapy for Prostate Cancer (GETUG-AFU 18)

UNICANCER

Phase NA Active not recruiting
500 enrolled
Genitourinary

Prostatic Neoplasms

NCT01954173 2022-03-02

Adjuvant Radiation for High Risk Bladder Cancer

Emory University

Phase NA Terminated
19 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡